After the 3rd U.S. Circuit Court of Appeals in Philadelphia called out Johnson &...
C2N Diagnostics introduced its second-generation liquid biopsy technology to det...
Interim analysis of the Neotorch trial revealed that the combo therapy could not...
The FDA approval was based on the data obtained from an open-label, pivotal Phas...
With lower screening rates, many of these cancers will probably be detected at a...
Novo Nordisk and Aspect enter a multimillion dollar partnership to produce pancr...
Foundation Medicine’s tissue-based test will be a companion diagnostic to BMS’s ...
Panbela will lead on the design of the global trial protocol.
The collaboration will leverage LyGenesis’s allogeneic cell therapy platform and...
The collaboration will advance the development of Xenetic’s systemic DNase progr...
Federal agencies in the US, Europe, and elsewhere are regulating the use of prim...
Pharming has made a $10m milestone payment to Novartis for the first commercial ...
Just how big of a pay bump do hospitals need from Medicare next year? The federa...
"It's critical patients and doctors have access to results to ascertain benefits...
Oracle has launched a new effort that will use AI to make use of the trove of da...
"We are entering dangerous, uncharted territory."
